<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Insight into GATA1 transcriptional activity through interrogation of cis elements disrupted in human erythroid disorders</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Aoi</forename><surname>Wakabayashi</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Broad Institute</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Jacob</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Broad Institute</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leif</forename><forename type="middle">S</forename><surname>Ludwig</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Broad Institute</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff3">
								<orgName type="department">Institute for Chemistry and Biochemistry</orgName>
								<orgName type="institution">Freie Universität Berlin</orgName>
								<address>
									<postCode>14195</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<postCode>10117</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Claudia</forename><surname>Fiorini</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Broad Institute</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Makiko</forename><surname>Yasuda</surname></persName>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Genetics and Genomic Sciences</orgName>
								<orgName type="department" key="dep2">Icahn School of Medicine at Mount Sinai</orgName>
								<address>
									<postCode>10029</postCode>
									<settlement>New York</settlement>
									<region>NY</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Avik</forename><surname>Choudhuri</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Department of Stem Cell and Regenerative Biology</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Patrick</forename><surname>Mcdonel</surname></persName>
							<affiliation key="aff2">
								<orgName type="institution">The Broad Institute</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Leonard</forename><forename type="middle">I</forename><surname>Zon</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Department of Stem Cell and Regenerative Biology</orgName>
								<orgName type="institution">Harvard University</orgName>
								<address>
									<postCode>02138</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Edited by David Ginsburg</orgName>
								<orgName type="institution" key="instit1">Howard Hughes Medical Institute</orgName>
								<orgName type="institution" key="instit2">Chevy Chase</orgName>
								<orgName type="institution" key="instit3">University of Michigan Medical School</orgName>
								<address>
									<postCode>20815</postCode>
									<settlement>Ann Arbor</settlement>
									<region>MD, MI</region>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Vijay</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
							<email>sankaran@broadinstitute.org</email>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Division of Hematology/Oncology</orgName>
								<orgName type="department" key="dep2">Manton Center for Orphan Disease Research</orgName>
								<orgName type="institution">Boston Children&apos;s Hospital</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Pediatric Oncology</orgName>
								<orgName type="department" key="dep2">Dana-Farber Cancer Institute</orgName>
								<address>
									<postCode>02115</postCode>
									<settlement>Boston</settlement>
									<region>MA</region>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="institution">The Broad Institute</orgName>
								<address>
									<postCode>02142</postCode>
									<settlement>Cambridge</settlement>
									<region>MA</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Insight into GATA1 transcriptional activity through interrogation of cis elements disrupted in human erythroid disorders</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">DC33E33C7F3FE29E97EE3BC2032E62D1</idno>
					<idno type="DOI">10.1073/pnas.1521754113</idno>
					<note type="submission">and approved March 3, 2016 (received for review November 3, 2015</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:24+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract/>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Whole-exome sequencing has been incredibly successful in identifying causal genetic variants and has revealed a number of novel genes associated with blood and other diseases.</s><s>One limitation of this approach is that it overlooks mutations in noncoding regulatory elements.</s><s>Furthermore, the mechanisms by which mutations in transcriptional cis-regulatory elements result in disease remain poorly understood.</s><s>Here we used CRISPR/Cas9 genome editing to interrogate three such elements harboring mutations in human erythroid disorders, which in all cases are predicted to disrupt a canonical binding motif for the hematopoietic transcription factor GATA1. Deletions of as few as two to four nucleotides resulted in a substantial decrease (&gt;80%) in target gene expression.</s><s>Isolated deletions of the canonical GATA1 binding motif completely abrogated binding of the cofactor TAL1, which binds to a separate motif.</s><s>Having verified the functionality of these three GATA1 motifs, we demonstrate strong evolutionary conservation of GATA1 motifs in regulatory elements proximal to other genes implicated in erythroid disorders, and show that targeted disruption of such elements results in altered gene expression.</s><s>By modeling transcription factor binding patterns, we show that multiple transcription factors are associated with erythroid gene expression, and have created predictive maps modeling putative disruptions of their binding sites at key regulatory elements.</s><s>Our study provides insight into GATA1 transcriptional activity and may prove a useful resource for investigating the pathogenicity of noncoding variants in human erythroid disorders.</s></p><p><s>GATA1 | cis-regulatory elements | noncoding mutations | Mendelian erythroid disorders W hole-exome sequencing (WES) and targeted sequencing approaches have greatly accelerated our ability to identify causal genetic lesions in both previously implicated and novel genes underlying monogenic disorders <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b1">2)</ref>.</s><s>In hematology, WES has been extremely useful for identifying unknown genetic etiologies for various disorders, such as those affecting red blood cell (RBC) production, including Diamond-Blackfan anemia and congenital dyserythropoietic anemia <ref type="bibr" target="#b2">(3)</ref><ref type="bibr" target="#b3">(4)</ref><ref type="bibr" target="#b4">(5)</ref>, disorders of RBC structure and function <ref type="bibr" target="#b5">(6,</ref><ref type="bibr" target="#b6">7)</ref>, and disorders affecting other aspects of hematologic function <ref type="bibr" target="#b1">(2,</ref><ref type="bibr" target="#b7">8)</ref>.</s><s>Despite this considerable success, however, more than 50% of cases of presumed monogenic diseases are refractory to current WES approaches <ref type="bibr" target="#b8">(9)</ref>.</s><s>Although resolving these remaining cases will benefit from improvements in exome capture <ref type="bibr" target="#b9">(10)</ref>, read alignment <ref type="bibr" target="#b10">(11)</ref>, and variant annotation methodologies <ref type="bibr" target="#b10">(11)</ref>, the importance of genetic variation occurring within regulatory elements (REs) outside of the traditionally investigated coding sequences in hematologic and other diseases is being increasingly appreciated <ref type="bibr" target="#b11">(12)</ref>.</s></p><p><s>Whole-genome sequencing (WGS) approaches are becoming progressively more available and affordable, but separating pathogenic genetic variation from benign or unrelated mutations remains especially difficult outside of protein-coding genetic regions <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b12">13)</ref>.</s><s>This difficulty is most clearly reflected in the distribution of mutations listed in databases of Mendelian disorders, such as the Human Gene Mutation Database, where most mutations are found within coding regions (86%) or at intronic splice sites (11%), with only a small fraction (3%) identified in regulatory regions <ref type="bibr" target="#b13">(14)</ref>.</s><s>Newer methods for annotating and predicting the impact of noncoding (NC) variants have provided substantial improvements <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>, but experimental validation of the presumed effects remains critical for the determination of pathogenicity and elucidation of the mechanism of action <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b16">17)</ref>.</s></p><p><s>Multiple lines of evidence have shown that NC mutations can modulate the transcriptional activity and binding of key cell typespecific master transcription factors (TFs) <ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b18">19)</ref>.</s><s>In several Mendelian erythroid disorders (MEDs), NC genetic variants have been identified in the DNA-binding motif (WGATAR) of the hematopoietic master regulator, GATA1 <ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref><ref type="bibr" target="#b23">(24)</ref><ref type="bibr" target="#b24">(25)</ref>.</s><s>GATA1 is both necessary for proper erythropoiesis <ref type="bibr" target="#b2">(3,</ref><ref type="bibr" target="#b25">26)</ref> and sufficient to reprogram alternative lineages toward an erythroid fate <ref type="bibr" target="#b26">(27,</ref><ref type="bibr" target="#b27">28)</ref>.</s><s>Moreover, numerous studies have shown that GATA1 acts in a</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Significance</head><p><s>Methods for identifying causal variants underlying human diseases have been greatly enhanced by whole-exome sequencing; however, this approach overlooks mutations that occur within noncoding regulatory regions.</s><s>Moreover, the mechanisms for how such mutations result in disease are poorly understood.</s><s>In this study, we interrogated binding sites of the blood cell transcription factor GATA1 in regulatory elements that are mutated in cases of human red blood cell disorders by creating small-targeted deletions in model cell lines.</s><s>These deletions cause a major reduction in target gene expression.</s><s>We used this initial insight to show that such elements are highly conserved, and that through predictive modeling, we can gain global insight into key determinants of GATA1 transcriptional activity.</s></p><p><s>number of multimeric complexes involving other TFs and can activate or repress target gene expression <ref type="bibr" target="#b28">(29)</ref><ref type="bibr" target="#b29">(30)</ref><ref type="bibr" target="#b30">(31)</ref><ref type="bibr" target="#b31">(32)</ref><ref type="bibr" target="#b32">(33)</ref><ref type="bibr" target="#b33">(34)</ref><ref type="bibr" target="#b34">(35)</ref><ref type="bibr" target="#b35">(36)</ref><ref type="bibr" target="#b36">(37)</ref>.</s></p><p><s>Although much has been learned about transcriptional regulation during erythropoiesis, the determinants of GATA1 activity at individual REs are incompletely understood <ref type="bibr" target="#b28">(29)</ref>.</s><s>For example, after Gata1 induction in the Gata1-null G1E-ER4 erythroblast (EB) cell line, GATA1 binds to and up-regulates key erythroid genes to induce terminal erythroid differentiation, while simultaneously repressing genes involved in alternative lineages.</s><s>The global chromatin architecture is indistinguishable between induced and repressed genes, however, suggesting that additional features, such as DNA sequence requirements and combinatorial TF patterns, determine the resulting transcriptional alterations in this model system and also more generally during lineage commitment and differentiation <ref type="bibr">(29-31, 34, 35, 37-42)</ref>.</s><s>Furthermore, the effects of genetic variation on erythroid cis-regulatory elements (CREs), particularly with regard to those predicted to disrupt GATA1 or cofactor (CF) motifs on GATA1 and CF binding and target gene expression, are not well defined <ref type="bibr" target="#b39">(40)</ref>.</s></p><p><s>Given these deficiencies, we interrogated three regions harboring rare variants implicated in distinct MEDs that are predicted to disrupt GATA1 motifs, using a combination of experimental and computational approaches to gain further insight into GATA1 transcriptional activity <ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref><ref type="bibr" target="#b42">43)</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p><s>Using Genome Editing to Verify NC Mutations Implicated in MEDs.</s><s>We selected single nucleotide mutations implicated in X-linked sideroblastic anemia (XLSA) <ref type="bibr" target="#b20">(21,</ref><ref type="bibr" target="#b21">22)</ref>, congenital erythropoietic porphyria (CEP) <ref type="bibr" target="#b19">(20)</ref>, and pyruvate kinase deficiency (PKD) <ref type="bibr" target="#b22">(23,</ref><ref type="bibr" target="#b42">43)</ref> that were predicted to disrupt a GATA1 binding site (BS) (Fig. <ref type="figure" target="#fig_0">S1</ref>).</s><s>In each case, the mutation fell within an erythroid CRE occupied by GATA1 and multiple CFs proximal to the known causal gene (ALAS2 in XLSA, UROS in CEP, and PKLR in PKD) (Fig. <ref type="figure" target="#fig_0">1 A-C</ref>).</s><s>To verify the effects of each NC mutation, we used CRISPR/Cas9 genome editing to create precise doublestranded DNA breaks across the affected core "GATA" motif in the K562 erythroid cell line, which shares a similar regulatory architecture at these CREs with primary human EBs (Fig. <ref type="figure" target="#fig_2">S2</ref>) <ref type="bibr" target="#b31">(32)</ref>.</s><s>We used a PCR-based screen to identify three to four clones with small deletions ranging in size from 2 to 15 nt across each motif resulting from unfaithful repair of the targeted double-stranded DNA breaks (Fig. <ref type="figure">S3</ref>).</s></p><p><s>For clonal GATA1 motif deletions in the intronic CREs of ALAS2 and UROS, we observed an ∼80% reduction of ALAS2 and UROS mRNA, but for clonal deletions in the PKLR promoter, we observed a &gt;99% reduction of PKLR mRNA (Fig. <ref type="figure" target="#fig_0">1D</ref>).</s><s>Deletions of as little as 2 nt were sufficient to reduce target mRNA transcription by &gt;80%, similar to findings in reporter assays <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b43">44)</ref>.</s><s>Although these results verify the functionality of the selected mutations, they also suggest that not all GATA1 BS variants will affect gene expression equally.</s><s>In our experiments, GATA1 motif deletion in a promoter resulted in complete abrogation of target gene expression, whereas residual target mRNA expression was still detectable in deletions at intronic CREs.</s><s>In addition, secondary intronic CREs occupied by GATA1 and TAL1 within ALAS2 and UROS may additively regulate gene expression; no secondary CREs were detected near PKLR (Fig. <ref type="figure" target="#fig_0">1 A-C</ref>).</s></p><p><s>As a proof of principle that this approach can validate variants in a disease-relevant context, we used a lentiviral CRISPR/Cas9 approach to target these GATA1 motifs in adult CD34 + hematopoietic stem and progenitor cells (HSPCs).</s><s>By targeting the CRE proximal to ALAS2, we observed a specific reduction in ALAS2 mRNA expression; we obtained similar results by targeting the CRE proximal to UROS (Fig. <ref type="figure" target="#fig_0">1E</ref>).</s><s>Importantly, the Cas9-infected HSPCs showed no impairment in their ability to undergo robust erythroid differentiation (Fig. <ref type="figure" target="#fig_0">1F</ref>).</s></p><p><s>Isogenic Cellular Models Phenocopy Cell-Intrinsic Effects of Associated Disorders.</s><s>We next set out to determine the extent to which our cellular models of NC GATA1 BS mutations could phenocopy the cell-intrinsic effects of each associated MED.</s><s>In XLSA, mutations in ALAS2, the gene encoding for δ-aminolevulinic acid synthase 2, the rate-limiting enzyme in heme biosynthesis, result in decreased heme production, promoting formation of the characteristic ringed sideroblasts (Fig. <ref type="figure" target="#fig_2">2A</ref>).</s><s>Thus, we performed a heme quantification assay and verified a decrease in heme levels of ∼40% in our XLSA model compared with isogenic controls (Fig. <ref type="figure" target="#fig_2">2A, Right</ref>).</s><s>Residual heme production is likely attributable to the small amount (∼20%) of ALAS2 mRNA expression and the moderate levels of the ubiquitously expressed δ-aminolevulinic acid synthase 1 (encoded by ALAS1) in the cells (Fig. <ref type="figure">S4</ref>).</s></p><p><s>Similar to XLSA, CEP is also a disorder of dysregulated heme biosynthesis.</s><s>Although mutations in UROS, the gene encoding uroporphyrinogen III synthase, also result in mildly reduced heme production, the phototoxicity and hemolysis observed in CEP are attributable primarily to accumulation of the toxic nonphysiological coproporphyrin I isomers (Fig. <ref type="figure" target="#fig_2">2B</ref>) <ref type="bibr" target="#b19">(20)</ref>.</s><s>To measure this accumulation in our CEP model, we performed a porphyrin assay, and found that our CRISPR-edited clones had an approximately fourfold higher ratio of isomer I to isomer III porphyrins compared with controls (Fig. <ref type="figure" target="#fig_2">2B</ref>, Right).</s></p><p><s>Finally, we investigated our cellular models of PKD, one of the most common causes of hereditary nonspherocytic hemolytic anemia  Interestingly, although PKLR is the only PK expressed in the committed erythroid lineage in humans, K562 cells strongly express PKM, an alternative PK, suggesting that even though PKLR is nearly absent in our PKD model, PKM alone is able to sustain glycolysis (Fig. <ref type="figure" target="#fig_2">2C</ref>, Bottom Right).</s><s>Overall, by disrupting specific GATA1 BSs, our cellular models are able to mimic the cell-intrinsic effects of XLSA, CEP, and PKD to varying degrees.</s></p><p><s>Targeted Disruption of the Core GATA Motif Destabilizes GATA1 TF Complexes.</s><s>As a master regulator of erythropoiesis, GATA1 often acts in a multimeric complex comprising TAL1 as well as the non-DNA-binding TFs LMO2 and LDB1, which can loop from CRE to promoter to regulate gene expression <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b34">(35)</ref><ref type="bibr" target="#b35">(36)</ref><ref type="bibr" target="#b36">(37)</ref>.</s><s>Mutations in the TAL1 motif (occurring 8-9 nt from a GATA1 motif) have been shown to modulate gene expression by significantly displacing both TAL1 and LDB1 while exhibiting only marginal effects on GATA1 binding <ref type="bibr" target="#b39">(40)</ref>.</s><s>Although we have shown that mutations in the GATA1 motif itself can affect target gene expression, resulting in disease, little is known about how these mutations affect binding of the entire activation complex.</s><s>Thus, we selected clones with the smallest GATA1 motif deletions (maximum 4 nt) and performed ChIP followed by PCR (ChIP-PCR) for TAL1, the other DNA-binding component of the multimeric complex (whose canonical motif was not disrupted).</s><s>Interestingly, all three GATA1 mutations resulted in a complete loss of TAL1 binding compared with both the GFP control and cross-isogenic control cells (Fig. <ref type="figure">3 A-C</ref>).</s><s>Thus, we provide direct evidence for a previously proposed model in which both TAL1 and GATA1 binding are important for proper erythroid gene expression, TAL1 binding is dependent on GATA1 <ref type="bibr" target="#b36">(37,</ref><ref type="bibr" target="#b45">46)</ref>, but GATA1 binding appears to be only partially dependent on TAL1 (Fig. <ref type="figure">3D</ref>) <ref type="bibr" target="#b39">(40)</ref>.</s></p><p><s>Evolutionary Conservation and Functional Relevance of GATA Motifs in Erythroid REs.</s><s>Although WES has uncovered many unexpected and novel genes underlying MEDs, including GATA1 in Diamond-Blackfan anemia and KCNN4 in hereditary xerocytosis (3, 7), causal genetic lesions have not been definitively identified in coding regions for a large percentage of Mendelian cases with clinical phenotypes <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b47">47,</ref><ref type="bibr" target="#b48">48)</ref>.</s><s>This suggests the possibility that an important minority of causal genetic lesions may instead be located within NC regulatory regions.</s><s>Given that we have verified that mutations identified in GATA1 BSs are pathogenic for three distinct MEDs, we wanted to investigate these BSs for other MEDs in which the known genetic defects act intrinsically within the erythroid lineage (www.bloodgenes.org/MEDs.html).</s></p><p><s>We first enumerated all CREs occupied by GATA1 in primary human EBs that are proximal to the ∼20 known pathogenic MED genes.</s><s>Within these CREs, we identified 176 core GATA sites, and investigated the evolutionary conservation of these four nucleotides as a proxy for functionality <ref type="bibr" target="#b31">(32,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b47">47,</ref><ref type="bibr" target="#b48">48)</ref>.</s><s>Surprisingly, although we observed only slight conservation for the GATA site within all ∼20,000 GATA1 chromatin occupancy sites across the genome, GATA sites within MED CREs were substantially conserved (Fig. <ref type="figure">4A</ref>) <ref type="bibr" target="#b31">(32)</ref>.</s><s>Moreover, the region containing the TAL1 motif 8-9 nt upstream of the core GATA motif was specifically conserved in a subset of MED CREs, suggesting the importance and functionality of both factors at these elements (Fig. <ref type="figure">4B</ref>) <ref type="bibr" target="#b36">(37)</ref>.</s><s>Therefore, we suggest that GATA1, and in certain cases TAL1, DNA BSs may harbor mutations in MED cases without identifiable and pathogenic genetic lesions within the coding sequence of the known MED genes.</s></p><p><s>To experimentally verify that disruption of these GATA1 motifs could affect expression of the target MED genes, we performed CRISPR/Cas9 genome editing at GATA1 motifs within seven CREs proximal to four MED genes.</s><s>For five of the seven targeted CREs, we observed a significant decrease in target gene expression (ranging from ∼30% to 80%) (Fig. <ref type="figure">4</ref> C-F and Fig. <ref type="figure" target="#fig_4">S5</ref>).</s><s>(Interestingly, we observed that targeting the other two CREs resulted in increased mRNA expression of the target gene, SLC4A1.)</s><s>Because we measured mRNA expression only in bulk cells, this finding is likely an underestimation of the true effect of the GATA1 motif disruption.</s><s>Interestingly, GATA1 appears to regulate genes implicated in disorders of the RBC membrane (EPB41 and KCNN4), various enzyme-related diseases (PKLR and HK1), and disorders occurring within the heme biosynthetic pathway (ALAS2 and UROS), suggesting that mutations in GATA1 BSs may occur in a number of distinct MEDs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Understanding and Predicting the Effects of NC Mutations on GATA1</head><p><s>and CFs.</s><s>Finally, we aimed to gain a better global understanding of the combinatorics of erythroid transcriptional regulation and to identify the important DNA elements underlying these TFs <ref type="bibr">(31-33, 38, 39, 41)</ref>.</s><s>To do so, we first used ChIP-seq to define the relative binding of GATA1 and four CFs generally implicated in an activation complex with GATA1: TAL1, LDB1, KLF1, and NFE2 <ref type="bibr">(31-35, 37, 39)</ref>.</s><s>Modeling the relative binding intensities of these CFs across the proximal promoters of ∼18,000 genes revealed that these five factors alone explained 46% of the variation in proerythroblast (proE) gene expression (Fig. <ref type="figure" target="#fig_4">5A</ref>).</s></p><p><s>We next investigated combinatorial binding patterns using partitioning around medoids (PAM), and identified six clusters of variable combinations of binding by GATA1 and CFs (Fig. <ref type="figure" target="#fig_4">5B</ref> and Fig. <ref type="figure">S6</ref>).</s><s>The first five clusters exhibited concomitant GATA1, TAL1, KLF1, and NFE2 binding intensity, associated with increasing expression during terminal erythroid differentiation (Fig. <ref type="figure" target="#fig_4">5C</ref>).</s><s>Interestingly, cluster 6 was differentiated from the other clusters by substantially greater LDB1 and TAL1 promoter binding, greater LDB1 binding at distal CREs (Fig. <ref type="figure">S7</ref>), and stronger transcriptional induction during terminal erythropoiesis (Fig. <ref type="figure" target="#fig_4">5 B and C</ref>) <ref type="bibr" target="#b34">(35)</ref>.</s><s>In addition, many MED genes, as well as the erythroid TFs themselves, were found within clusters with strong erythroid TF intensity (Fig. <ref type="figure" target="#fig_4">5C</ref>).</s><s>Building on previous work <ref type="bibr">(31-33, 38, 39, 41)</ref>, our results provide additional evidence that the cooperation of these five TFs is important for the proper expression of key erythroid genes, such as those mutated in MEDs.</s></p><p><s>Given the importance of multiple TFs in our model, we dissected the DNA elements of CREs at the known MED genes using two state-of-the-art approaches to predict the cell typespecific effects of NC mutations.</s><s>First, we trained a gapped k-mer support vector machine (gkmer-SVM) on EB and K562 open chromatin data and used delta-SVM to predict single nucleotide effects <ref type="bibr" target="#b15">(16)</ref>.</s><s>We then used already-trained models for the TFs GATA1, TAL1, KLF1, and NFE2 from DeepBind, a convolutional neural network approach <ref type="bibr" target="#b14">(15)</ref>.</s><s>For each CRE proximal to the 20 MED genes, we created a "mutation map" of the predicted effects of all possible single nucleotide changes <ref type="bibr" target="#b14">(15)</ref>.</s></p><p><s>For each GATA1 motif that we functionally verified with CRISPR/Cas9 genome editing, our models show that a single nucleotide change in the core GATA is predicted to completely abolish binding, consistent with our in vitro results and the in vivo phenotypes in patients with cis-regulatory mutations (Fig. <ref type="figure" target="#fig_4">5D</ref> and Fig. <ref type="figure">S8</ref>).</s><s>Moreover, the mutation maps suggest that TAL1 binding is more strongly affected by alterations to the GATA1 motif than by alterations to its own motif, consistent with our TAL1 ChIP-PCR results (Fig. <ref type="figure" target="#fig_4">5D</ref> and Fig. <ref type="figure">S8</ref>).</s><s>To further demonstrate the utility of our mutation maps, we determined that mutations reported in two independent cases of PKD (in what was previously known as the PKLR-RE1 element) actually disrupted the TAL1 motif proximal to the interrogated GATA1 motif (Fig. <ref type="figure" target="#fig_4">5D</ref>) <ref type="bibr" target="#b49">(49,</ref><ref type="bibr">50)</ref>, highlighting the important role of GATA1 CFs in regulating proper gene transcription during erythropoiesis <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b39">40)</ref>.</s><s>We also observed multiple "complex" REs containing multiple TF binding motifs.</s><s>For example, at a CRE occupied by GATA1, TAL1, KLF1, LDB1, and NFE2 in the eighth intron of ALAS2, our mutation maps identified multiple GATA1 and TAL1 motifs, as well as a KLF1 motif and an NFE2 motif (Fig. <ref type="figure" target="#fig_4">5E</ref>).</s><s>Exogenous reporter assays have shown that, depending on the exact "chunks" of DNA tested, this region can vary in activation strength and even repress <ref type="bibr" target="#b51">(51)</ref>.</s><s>Intriguingly, when we separately targeted two GATA1 motifs in ALAS2 intron 8 with CRISPR/Cas9, we observed an increase in ALAS2 mRNA expression, similar to the results obtained by targeting two CREs near SLC4A1, suggesting that these regions may have a particularly complex regulatory architecture (Fig. <ref type="figure">S9</ref>) <ref type="bibr" target="#b51">(51)</ref>.</s><s>Taken together, our analyses provide additional evidence that erythroid CREs are dependent on the binding of multiple TFs for proper transcriptional regulation and RBC development.</s><s>We provide visualizations of the regulatory landscape of MED genes, gene expression graphs, and mutation maps across CREs for each MED on our website (www.bloodgenes.org/MEDs.html).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p><s>In this study, we interrogated natural genetic variations occurring in MEDs to provide a window into the functions of erythroid gene regulatory networks <ref type="bibr" target="#b1">(2)</ref>.</s><s>In primary HSPCs and an erythroid cell line, we used CRISPR/Cas9 genome editing to verify the regulatory effects of NC genetic variants associated with XLSA, CEP, and PKD, and were able to recapitulate the cellintrinsic phenotypes of the associated disorder <ref type="bibr" target="#b19">(20)</ref><ref type="bibr" target="#b20">(21)</ref><ref type="bibr" target="#b21">(22)</ref><ref type="bibr" target="#b22">(23)</ref><ref type="bibr" target="#b42">43)</ref>.</s><s>These immortalized cellular models are readily available for the study of disease pathology and may prove useful for screening potential treatments, such as gene therapy <ref type="bibr" target="#b52">(52)</ref>.</s><s>More generally, our approach to experimentally validate the pathogenicity of rare NC variants can be applied to novel NC variants associated with erythroid or nonerythroid Mendelian diseases.</s></p><p><s>During the process of functionally verifying the selected mutations, we determined that small alterations (2-4 nt) of a GATA1 motif were sufficient to reduce expression of the known causal gene by &gt;80% in all cases; although the exact effects of each single nucleotide variant observed in vivo remains to be shown.</s><s>Mechanistically, we showed that by solely disrupting the GATA1 BS at a CRE, the binding of the DNA-binding CF TAL1 is severely impaired, likely resulting in loss of the entire CF-containing multimeric complex <ref type="bibr" target="#b34">(35,</ref><ref type="bibr" target="#b36">37)</ref>.</s><s>Our analysis of combinatorial occupancy patterns of erythroid TFs highlights the importance of this multimeric complex formed by GATA1, TAL1, and LDB1 for the induction of key erythroid genes during terminal erythropoiesis <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b40">41)</ref>.</s><s>In contrast to the GATA1 BSs interrogated here, our predictive maps and other studies have shown that mutations in TAL1 BSs have only marginal effects on GATA1 binding, while still resulting in altered gene expression <ref type="bibr" target="#b39">(40)</ref>.</s></p><p><s>Another important finding from the present study is that similar GATA1 motif deletions did not always result in a complete abrogation of target gene expression.</s><s>Although more examples are needed to confirm the exact principles and extent of context dependence (i.e., promoter vs. intronic/distal CRE), our results primarily suggest the possibility of enhancer additivity.</s><s>Our investigation of multiple CREs proximal to EPB41, HK1, ALAS2, and SLC4A1 showed that each CRE independently regulated the expression of its target gene.</s></p><p><s>Finally, determining the pathogenicity and/or causality of NC genetic variants that either result in disease or modify disease severity remains difficult <ref type="bibr" target="#b12">(13,</ref><ref type="bibr" target="#b53">53)</ref>.</s><s>To address this, we coupled experimental and bioinformatics approaches to show that mutations in GATA1 and CF BSs can substantially affect genes implicated in MEDs, and created mutation maps of predicted mutations across CREs proximal to MED genes <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>.</s><s>These maps may prove useful for prioritizing variants from WGS or targeted sequencing of MED cases, as we have initially shown for PKLR-RE1 mutations that disrupt a TAL1 binding motif, and can identify disruptive as well as gain-of-function mutations.</s><s>Nevertheless, our maps might not represent all regulatory modalities, such as the effects of currently unassayed TFs or complex REs (i.e., barrier insulators) <ref type="bibr" target="#b54">(54)</ref>.</s><s>Furthermore, experimental validation of an associated variant (using, e.g., CRISPR/Cas9 genome editing) remains the cornerstone for determining causality <ref type="bibr" target="#b12">(13)</ref>.</s><s>Altogether, our combined approach for interrogating NC genetic variation reveals important aspects of both GATA1 transcriptional activity and erythroid CREs, and likely will prove useful for identifying and dissecting NC mutations in MEDs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head><p><s>Experimental Outline.</s><s>K562 cells were cotransfected with Cas9 nuclease and sgRNA plasmids and subjected to puromycin selection and limiting dilutions.</s><s>Clones were screened for small deletions of the WGATAR motif via PCR, and successful clones were selected for downstream assays.</s><s>The experimental procedures are described in detail in SI Materials and Methods.</s></p><p><s>Bioinformatic and Statistical Analyses.</s><s>Unless specified otherwise, the twotailed Student t test was used for comparisons between groups.</s><s>ChIP-seq and RNA-seq were processed as described previously <ref type="bibr" target="#b31">(32)</ref>.</s><s>Random forests were used to model expression, k-means and PAM were used for clustering, and gkmer-SVM and DeepBind were used to create mutation maps <ref type="bibr" target="#b14">(15,</ref><ref type="bibr" target="#b15">16)</ref>.</s><s>Complete details are available in SI Materials and Methods.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig. 1.</s><s>Using genome editing to verify NC mutations associated with MED.</s><s>(A-C) GATA1, TAL1, LDB1, KLF1, and NFE2 occupancy and nucleosome-depleted regions (NDRs) across ALAS2, UROS, and PKLR in primary proEs.</s><s>The orange highlighted region indicates the target GATA1 BS targeted by CRISPR/Cas9.</s><s>The sgRNA used for genome editing is shown, and its PAM sequence is shown in green.</s><s>The red arrows indicate mutations associated with MEDs.</s><s>(D) Relative mRNA expression levels of ALAS2, UROS, and PKLR across clonal deletions of the associated GATA1 BS. ****P &lt; 0.0001.</s><s>(E) Relative mRNA expression levels of ALAS2 and UROS on day 10 of differentiation with a vector containing Cas9 and a nontargeting sgRNA (black; sgXPR5) or sgRNAs targeting the GATA1 motif in the CRE near ALAS2 (red; sgALAS2) or near UROS (orange, sgUROS).</s><s>*P &lt; 0.05; **P &lt; 0.01; n.s., P nonsignificant.</s><s>(F) CD235a expression at day 12 of differentiation in infected HSPCs.</s><s>Unstained control cells are shown in gray.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>( 45 )</head><label>45</label><figDesc><div><p><s>. Pyruvate kinase (PK), encoded by PKLR, catalyzes the final reaction of glycolysis by converting phosphoenolpyruvate to pyruvate (Fig.2C, Top Left).</s><s>We first measured intracellular levels of mature PKLR protein and confirmed a reduction in our CRISPR-edited clones (Fig.2C, Bottom Left).</s><s>Nevertheless, a PK enzymatic activity assay revealed only weakly to moderately reduced activity in the CRISPR-edited clones compared with controls (Fig.2C, Top Right).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 2 .</head><label>2</label><figDesc><div><p><s>Fig. 2. Functional characterization of CRISPR-edited K562 clones modeling XLSA, PKD, and CEP.</s><s>(A) (Left) Flowchart of the heme biosynthesis pathway.</s><s>ALAS2 is the rate-limiting enzyme in this pathway, and its disruption leads to decreased heme production.</s><s>(Right) Relative amounts (in μM) of heme normalized to cell number.</s><s>****P &lt; 0.0001.</s><s>(B) (Left) Schematic of the extracellular portion of the heme biosynthesis pathway.</s><s>δ-aminolevulinic acid is stepwise converted to hydroxymethylbilane, which is then synthesized into uroporphyrin III by UROS, eventually resulting in heme production.</s><s>Without UROS, hydroxymethylbilane is processed into nonphysiological isomer I porphyrins, resulting in hemolysis and UV phototoxicity.</s><s>(Right) Ratios of coproporphyrin I to coproporphyrin III values.</s><s>****P &lt; 0.0001.</s><s>(C) (Top Left) Diagram showing the final step of glycolysis.</s><s>PKLR catalyzes this conversion of phosphoenolpyruvate (PEP) to pyruvate.</s><s>(Bottom Left) Intracellular flow cytometry analysis for PKLR.</s><s>(Top Right) PK enzymatic activity assay.</s><s>(Bottom Right) Expression of genes encoding PK, PKLR and PKM, during erythroid differentiation and in K562 cells.</s></p></div></figDesc><graphic coords="3,117.17,374.13,106.22,63.74" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 3 .Fig. 4 .</head><label>34</label><figDesc><div><p><s>Fig. 3. Mutations in GATA1 BSs affect CF binding.</s><s>(A-C) ChIP-PCR results against rabbit IgG negative control and TAL1 antibody for the ALAS2 intron (A), the UROS intron (B), and the PKLR promoter (C).</s><s>*P &lt; 0.05; **P &lt; 0.01; ***P &lt; 0.001; ****P &lt; 0.0001; n.s., P nonsignificant.</s><s>(D) Model of mutations in a standard activation complex involving GATA1.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5. Identifying key TF occupancy patterns and predicting important DNA REs near human MED genes.</s><s>(A) Plot comparing observed and predicted proE expression from the predictive model of TF binding intensities.</s><s>Hexagonal binning is used to represent point density.</s><s>(B) Identification of six clusters representing the z-scores of the promoter binding intensities of erythroid TFs.</s><s>(C ) Comparison of gene expression during lineage commitment and terminal erythroid differentiation across the clusters derived in B. The pie chart shows that MED genes reside within clusters with greater GATA1 and CF binding intensities.</s><s>(D) Mutation map of the PKLR promoter for GATA1 and TAL1 binding.</s><s>Predicted loss-of-function mutations are in blue, gain-of-function mutations are in red, and benign mutations are in white.</s><s>Stars indicate previously reported mutations in cases of PKD.</s><s>The GATA1 and TAL1 motifs are highlighted in orange and green, respectively.</s><s>(E) A mutation map of a CRE in the eighth intron of ALAS2, similar to D.</s></p></div></figDesc><graphic coords="5,132.65,66.57,143.55,173.78" type="bitmap" /></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="4436">| www.pnas.org/cgi/doi/10.1073/pnas.1521754113 Wakabayashi et al.</note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" n="4438">| www.pnas.org/cgi/doi/10.1073/pnas.1521754113 Wakabayashi et al.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>ACKNOWLEDGMENTS.</s><s>We thank B. Cleary, C. Fulco, R. Tewhey, D. Bishop, and members of the V.G.S. laboratory for valuable comments and discussions.</s><s>This work was supported by National Institutes of Health Grants R01 DK103794 and R21 HL120791 (to V.G.S.).</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Exome sequencing as a tool for Mendelian disease gene discovery</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Bamshad</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Genet</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="745" to="755" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Applications of high-throughput DNA sequencing to benign hematology</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Gallagher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="3575" to="3582" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">122</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="2439" to="2443" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I</title>
		<author>
			<persName><forename type="first">C</forename><surname>Babbs</surname></persName>
			<affiliation>
				<orgName type="collaboration">WGS500 Consortium</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1383" to="1387" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">X-linked macrocytic dyserythropoietic anemia in females with an ALAS2 mutation</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">125</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1665" to="1669" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Mutations in the mechanotransduction protein PIEZO1 are associated with hereditary xerocytosis</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zarychanski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1908" to="1915" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Mutations in the Gardos channel (KCNN4) are associated with hereditary xerocytosis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Glogowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lezon-Geyda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Maksimova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Gallagher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">126</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1281" to="1284" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA)</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Finberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="569" to="571" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Clinical whole-exome sequencing for the diagnosis of mendelian disorders</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Yang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="issue">16</biblScope>
			<biblScope unit="page" from="1502" to="1511" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Performance comparison of four exome capture systems for deep sequencing</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Chilamakuri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Genomics</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page">449</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">A survey of tools for variant analysis of next-generation genome sequencing data</title>
		<author>
			<persName><forename type="first">S</forename><surname>Pabinger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brief Bioinform</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="256" to="278" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Interpreting noncoding genetic variation in complex traits and human disease</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Ward</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kellis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1095" to="1106" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Guidelines for investigating causality of sequence variants in human disease</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Macarthur</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">508</biblScope>
			<biblScope unit="issue">7497</biblScope>
			<biblScope unit="page" from="469" to="476" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Genes, mutations, and human inherited disease at the dawn of the age of personalized genomics</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Cooper</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hum Mutat</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="631" to="655" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Predicting the sequence specificities of DNA-and RNA-binding proteins by deep learning</title>
		<author>
			<persName><forename type="first">B</forename><surname>Alipanahi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Delong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Weirauch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Frey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Biotechnol</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="831" to="838" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">A method to predict the impact of regulatory variants from DNA sequence</title>
		<author>
			<persName><forename type="first">D</forename><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="955" to="961" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">FTO obesity variant circuitry and adipocyte browning in humans</title>
		<author>
			<persName><forename type="first">M</forename><surname>Claussnitzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">373</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="895" to="907" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Genetic and epigenetic fine mapping of causal autoimmune disease variants</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Farh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">518</biblScope>
			<biblScope unit="issue">7539</biblScope>
			<biblScope unit="page" from="337" to="343" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Genetic variation determines PPARγ function and anti-diabetic drug response in vivo</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Soccio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="33" to="44" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Uroporphyrinogen III synthase erythroid promoter mutations in adjacent GATA1 and CP2 elements cause congenital erythropoietic porphyria</title>
		<author>
			<persName><forename type="first">C</forename><surname>Solis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Aizencang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Astrin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Desnick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="753" to="762" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">X-linked sideroblastic anemia due to ALAS2 intron 1 enhancer element GATA binding site mutations</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Campagna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Hematol</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="315" to="319" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kaneko</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Haematologica</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="252" to="261" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">A new PKLR gene mutation in the R-type promoter region affects the gene transcription causing pyruvate kinase deficiency</title>
		<author>
			<persName><forename type="first">L</forename><surname>Manco</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="993" to="997" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Mutation of the GATA site in the erythroid cell-specific regulatory element of the ABO gene in a Bm subgroup individual</title>
		<author>
			<persName><forename type="first">T</forename><surname>Nakajima</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transfusion</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="2917" to="2927" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Delta-thalassemia caused by disruption of the site for an erythroid-specific transcription factor, GATA-1, in the delta-globin gene promoter</title>
		<author>
			<persName><forename type="first">M</forename><surname>Matsuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Sakamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Fukumaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="1347" to="1351" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Analysis of disease-causing GATA1 mutations in murine gene complementation systems</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Wilkinson-White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Mackay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Matthews</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Blobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">26</biblScope>
			<biblScope unit="page" from="5218" to="5227" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">GATA-1 converts lymphoid and myelomonocytic progenitors into the megakaryocyte/erythrocyte lineages</title>
		<author>
			<persName><forename type="first">H</forename><surname>Iwasaki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="451" to="462" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">GATA-1 reprograms avian myelomonocytic cell lines into eosinophils, thromboblasts, and erythroblasts</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kulessa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Frampton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Graf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1250" to="1262" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Erythroid GATA1 function revealed by genome-wide analysis of transcription factor occupancy, histone modifications, and mRNA expression</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="2172" to="2184" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Dynamics of the epigenetic landscape during erythroid differentiation after GATA1 restoration</title>
		<author>
			<persName><forename type="first">W</forename><surname>Wu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1659" to="1671" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Identification of biologically relevant enhancers in human erythroid cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Y</forename><surname>Su</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="8433" to="8444" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Altered chromatin occupancy of master regulators underlies evolutionary divergence in the transcriptional landscape of erythroid differentiation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Ulirsch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS Genet</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page">e1004890</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Ldb1 complexes: Tthe new master regulators of erythroid gene transcription</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Love</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Warzecha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Genet</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="1" to="9" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Genome-wide ChIP-Seq reveals a dramatic shift in the binding of the transcription factor erythroid Kruppellike factor during erythrocyte differentiation</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Pilon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">118</biblScope>
			<biblScope unit="issue">17</biblScope>
			<biblScope unit="page" from="e139" to="e148" />
			<date type="published" when="2011">2011</date>
			<publisher>NISC Comparative Sequencing Center</publisher>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="4575" to="4585" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Role of LDB1 in the transition from chromatin looping to transcription activation</title>
		<author>
			<persName><forename type="first">I</forename><surname>Krivega</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">K</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dean</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1278" to="1290" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Genome-wide identification of TAL1&apos;s functional targets: Insights into its mechanisms of action in primary erythroid cells</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Kassouf</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="1064" to="1083" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Occupancy by key transcription factors is a more accurate predictor of enhancer activity than histone modifications or chromatin accessibility</title>
		<author>
			<persName><forename type="first">N</forename><surname>Dogan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epigenetics Chromatin</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="16" to="36" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">KLF1 stabilizes GATA-1 and TAL1 occupancy in the human β-globin locus</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">W</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Yun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochim Biophys Acta</title>
		<imprint>
			<biblScope unit="volume">1849</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="282" to="289" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Editing the genome to introduce a beneficial naturally occurring mutation associated with increased fetal globin</title>
		<author>
			<persName><forename type="first">B</forename><surname>Wienert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Commun</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="7085" to="7092" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1, and Ldb1/NLI proteins</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Wadman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="3145" to="3157" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Combinatorial transcriptional control in blood stem/progenitor cells: Genome-wide analysis of ten major transcriptional regulators</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Stem Cell</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="532" to="544" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">A case of congenital red cell pyruvate kinase deficiency associated with hereditary stomatocytosis</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Marcello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood Cells Mol Dis</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="261" to="262" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Experimental validation of predicted mammalian erythroid cisregulatory modules</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1480" to="1492" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Red cell pyruvate kinase deficiency: Molecular and clinical aspects</title>
		<author>
			<persName><forename type="first">A</forename><surname>Zanella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Fermo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bianchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Valentini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Haematol</title>
		<imprint>
			<biblScope unit="volume">130</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="11" to="25" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main">Dynamic shifts in occupancy by TAL1 are guided by GATA factors and drive large-scale reprogramming of gene expression during hematopoiesis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Wu</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1945" to="1962" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title level="m" type="main">Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ballester</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2014">2014</date>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">e02626</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Principles of regulatory information conservation between mouse and human</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Cheng</surname></persName>
			<affiliation>
				<orgName type="collaboration">Mouse ENCODE Consortium</orgName>
			</affiliation>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">515</biblScope>
			<biblScope unit="issue">7527</biblScope>
			<biblScope unit="page" from="371" to="375" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Two novel missense mutations and a 5-bp deletion in the erythroid-specific promoter of the PKLR gene in two unrelated patients with pyruvate kinase-deficient transfusion-dependent chronic nonspherocytic hemolytic anemia</title>
		<author>
			<persName><forename type="first">L</forename><surname>Kager</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Blood Cancer</title>
		<imprint>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note>in press</note>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Disruption of a novel regulatory element in the erythroidspecific promoter of the human PKLR gene causes severe pyruvate kinase deficiency</title>
		<author>
			<persName><forename type="first">R</forename><surname>Wijk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1596" to="1602" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Identification and characterization of a conserved erythroid-specific enhancer located in intron 8 of the human 5-aminolevulinate synthase 2 gene</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Surinya</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Cox</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>May</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">273</biblScope>
			<biblScope unit="issue">27</biblScope>
			<biblScope unit="page" from="16798" to="16809" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Anemia: progress in molecular mechanisms and therapies</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="221" to="230" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Amelioration of Sardinian beta0 thalassemia by genetic modifiers</title>
		<author>
			<persName><forename type="first">R</forename><surname>Galanello</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">114</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="3935" to="3937" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Mutation of a barrier insulator in the human ankyrin-1 gene is associated with hereditary spherocytosis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Gallagher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="4453" to="4465" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Cyclin D3 coordinates the cell cycle during differentiation to regulate erythrocyte size and number</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">G</forename><surname>Sankaran</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genes Dev</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">18</biblScope>
			<biblScope unit="page" from="2075" to="2087" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">High-performance liquid chromatography of porphyrins</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">K</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Peters</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Chromatogr A</title>
		<imprint>
			<biblScope unit="volume">429</biblScope>
			<biblScope unit="page" from="123" to="153" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Transcription factor binding predictions using TRAP for the analysis of ChIP-seq data and regulatory SNPs</title>
		<author>
			<persName><forename type="first">M</forename><surname>Thomas-Chollier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Protoc</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1860" to="1869" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Combinatorial assembly of developmental stage-specific enhancers controls gene expression programs during human erythropoiesis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Dev Cell</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="796" to="811" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Analysis of chromatin-state plasticity identifies cell type-specific regulators of H3K27me3 patterns</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pinello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Orkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">C</forename><surname>Yuan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="E344" to="E353" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Regulation of nucleosome landscape and transcription factor targeting at tissue-specific enhancers by BRG1</title>
		<author>
			<persName><forename type="first">G</forename><surname>Hu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genome Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1650" to="1658" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Discovering hematopoietic mechanisms through genomewide analysis of GATA factor chromatin occupancy</title>
		<author>
			<persName><forename type="first">T</forename><surname>Fujiwara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell</title>
		<imprint>
			<biblScope unit="volume">36</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="667" to="681" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">An integrated encyclopedia of DNA elements in the human genome</title>
	</analytic>
	<monogr>
		<title level="m">Consortium EP; ENCODE Project Consortium</title>
				<imprint>
			<date type="published" when="2012">2012</date>
			<biblScope unit="volume">489</biblScope>
			<biblScope unit="page" from="57" to="74" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers</title>
		<author>
			<persName><forename type="first">R</forename><surname>Stadhouders</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="1699" to="1710" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Use model-based analysis of ChIP-seq (MACS) to analyze short reads generated by sequencing protein-DNA interactions in embryonic stem cells</title>
		<author>
			<persName><forename type="first">T</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="volume">1150</biblScope>
			<biblScope unit="page" from="81" to="95" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Global transcriptome analyses of human and murine terminal erythroid differentiation</title>
		<author>
			<persName><forename type="first">X</forename><surname>An</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="issue">22</biblScope>
			<biblScope unit="page" from="3466" to="3477" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
